About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘japan retractions’ Category

Paper about widely touted but unapproved “cure” for cancer, autism retracted

with 11 comments

int j cancerA paper about a protein being used — unapproved by health agencies — to treat diseases including cancer and autism has been retracted.

Here’s the notice from the International Journal of Cancer about a 2007 paper purporting to show that the substance, GcMAF, is useful against breast cancer: Read the rest of this entry »

About these ads

Publishing gadfly demands journal editor’s resignation, then has “fairly incomprehensible” paper rejected

with 48 comments

sci eng ethicsA scientific publishing gadfly who was banned earlier this year from an Elsevier journal for “personal attacks and threats” has had a paper rejected by a Springer journal after he called for the editor’s resignation because of alleged incompetence.

As detailed in a comment left at Retraction Watch, Jaime A. Teixeira da Silva submitted a manuscript titled “One Conjunction, a World of Ethical Difference: How Elsevier, the ICMJE and Neurology Define Authorship” to Science and Engineering Ethics on November 11, 2012. As of last week, despite a number of messages sent to editors of the journal, he had not had a decision on the manuscript.

As a result, on July 14 of this year, Teixeira da Silva sent this letter to journal editor Raymond Spier and to Stephanie Bird, an editorial board member assigned to the manuscript: Read the rest of this entry »

Written by Ivan Oransky

July 21, 2014 at 3:55 pm

STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems

with 12 comments

nature 714A significant chapter of the nearly six-month saga of the STAP stem cell controversy has come to an end, with Nature running retraction notices for the two papers involved. The journal has also published an editorial about the case that’s worth a read.

The retractions for “Bidirectional developmental potential in reprogrammed cells with acquired pluripotency” and “Stimulus-triggered fate conversion of somatic cells into pluripotency” both read: Read the rest of this entry »

RIKEN inquiry prompted by STAP stem cell controversy generates three corrections

with 8 comments

rikenlogo_enA review of past publications by the Japanese research institution RIKEN has produced three corrections of articles by a molecular geneticist, Haruhiko Koseki, The Scientist is reporting. The articles had appeared in Molecular and Cellular Biology between 2005 and 2010.

The review was triggered by the scandal involving Haruko Obokata, a former RIKEN scientist whose work on STAP stem cells has come under scrutiny. However, RIKEN officials said the corrections are unrelated to the Obokata case. Obokata has reportedly agreed to retract two of her articles in Nature. (RIKEN has released an English-language translation of its response to Obokata’s appeal against charges of research misconduct.)

According to The Scientist, Koseki was a member of a committee charged with investigating Obokata’s STAP results: Read the rest of this entry »

Written by amarcus41

June 23, 2014 at 11:00 am

UT-Southwestern cancer researchers up to 8 retractions

with 5 comments

oncogeneA group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.

Here’s the notice for 2005’s “Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection,” in Oncogene: Read the rest of this entry »

Obokata agrees to retract one of two STAP stem cell papers in Nature: Reports

with 18 comments

nature 2-27-14The Kyodo News service has reported that Haruko Obokata has agreed to retract one of the two Nature papers on an easy method of making stem cells.

According to the report: Read the rest of this entry »

Written by amarcus41

May 28, 2014 at 12:13 pm

Ninth retraction appears for cardiology researcher Matsubara

with 3 comments

matsubaraHiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher who resigned last year following an investigation, has had another paper retracted, his ninth.

Here’s the notice from Arteriosclerosis, Thrombosis, and Vascular Biology: Read the rest of this entry »

Shigeaki Kato up to 25 retractions

with 4 comments

Shigeaki Kato

Shigeaki Kato

Shigeaki Kato, who resigned from the University of Tokyo in 2012 after being found to have inappropriately manipulated dozens of images, has two more retractions, both in Molecular Cell.

Here’s the notice for 2002’s “Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex:” Read the rest of this entry »

Crystal unclear? “Business decision” forces retraction of silicon paper

with one comment

jcgrowthA group of researchers in Tokyo has lost their 2013 article in the Journal of Crystal Growth over commercial interests — which don’t appear to be their own.

We’ll explain.

The article, “Interactions between planar defects in bulk 3C-SiC,” came from a team consisting of a researcher at Keio University and scientists at two companies, HOYA Corporation, an optics firm, and SICOXS Corporation, which makes semiconductor wafers.

According to the abstract: Read the rest of this entry »

Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship

with 46 comments

Eriko Suzuki

Eriko Suzuki

Over the past week, there have been a number of comments on PubPeer — a site of which we’re big fans — about a 2007 paper in Oncogene.

The comments suggested that the figures in the paper had problems. Some bands seemed to be duplicated, and one of the images looked very much like that of another paper.

Then, today, first author Eriko Suzuki left this comment: Read the rest of this entry »

Follow

Get every new post delivered to your Inbox.

Join 33,783 other followers